Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Weiller

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2008
Sensitization by 5-azacytidine toward death receptor-induced hepatic apoptosisTimo Weiland, Markus Weiller, Gerald Künstle, et al.
Toxicology|August 7, 2004
Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytesMarkus Weiller, Markus Latta, Matthias Kresse, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|June 12, 2010
Differential immunotoxicity of histone deacetylase inhibitors on malignant and naïve hepatocytesMarkus Weiller, Timo Weiland, Georg Dünstl, et al.
Drug Delivery and Translational Research|March 15, 2023
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulinsPeter Leidenmühler, Joris Höfinghoff, Norbert Haider, et al.
Frontiers in Immunology|November 17, 2022
Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cellsChristian Lubich, Katharina Nora Steinitz, Brigitte Hoelbl, et al.
Blood|July 27, 2011
T cell-independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonistAniko G Pordes, Christina K Baumgartner, Peter Allacher, et al.
Molecular Therapy. Methods & Clinical Development|March 24, 2025
Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIIIJohannes Lengler, Markus Weiller, Franziska Horling, et al.
Pharmaceutical Research|June 19, 2013
Development of a transgenic mouse model with immune tolerance for human coagulation factor VIIaChristine Lenk, Sabine Unterthurner, Maria Schuster, et al.
Blood|June 28, 2011
Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse modelPauline M van Helden, Sabine Unterthurner, Corinna Hermann, et al.
Blood|March 8, 2012
CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 miceKatharina N Steinitz, Pauline M van Helden, Brigitte Binder, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2008
Sensitization by 5-azacytidine toward death receptor-induced hepatic apoptosisTimo Weiland, Markus Weiller, Gerald Künstle, et al.
Toxicology|August 7, 2004
Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytesMarkus Weiller, Markus Latta, Matthias Kresse, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|June 12, 2010
Differential immunotoxicity of histone deacetylase inhibitors on malignant and naïve hepatocytesMarkus Weiller, Timo Weiland, Georg Dünstl, et al.
Drug Delivery and Translational Research|March 15, 2023
In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulinsPeter Leidenmühler, Joris Höfinghoff, Norbert Haider, et al.
Frontiers in Immunology|November 17, 2022
Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cellsChristian Lubich, Katharina Nora Steinitz, Brigitte Hoelbl, et al.
Blood|July 27, 2011
T cell-independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonistAniko G Pordes, Christina K Baumgartner, Peter Allacher, et al.
Molecular Therapy. Methods & Clinical Development|March 24, 2025
Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIIIJohannes Lengler, Markus Weiller, Franziska Horling, et al.
Pharmaceutical Research|June 19, 2013
Development of a transgenic mouse model with immune tolerance for human coagulation factor VIIaChristine Lenk, Sabine Unterthurner, Maria Schuster, et al.
Blood|June 28, 2011
Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse modelPauline M van Helden, Sabine Unterthurner, Corinna Hermann, et al.
Blood|March 8, 2012
CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 miceKatharina N Steinitz, Pauline M van Helden, Brigitte Binder, et al.
Pageof 2